LOGO
LOGO

Pre-market Movers: VIGL, CVM, KDLY, VTAK...

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024 lt

In Thursday's pre-market trading, the biotech stocks which are making significant moves are: (as of 8.00 am ET).

In the Green

Vigil Neuroscience, Inc. (VIGL) is up over 242% at $7.90.
Kindly MD, Inc. (KDLY) is up over 18% at $27.00.
ALX Oncology Holdings Inc. (ALXO) is up over 10% at $0.45.
Sutro Biopharma, Inc. (STRO) is up over 10% at $0.92.
Instil Bio, Inc. (TIL)is up over 10% at $17.94.
Ventyx Biosciences, Inc. (VTYX) is up over 9% at $1.67.
Helius Medical Technologies, Inc. (HSDT) is up over 9% at $4.75.
GT Biopharma, Inc. (GTBP) is up over 8% at $2.89.
Ontrak, Inc. (OTRK)is up over 8% at $1.69.
Lipocine Inc. (LPCN) is up over 7% at $3.88.
Quantum-Si incorporated (QSI) is up over 5% at $1.56.
AVITA Medical, Inc. (RCEL) is up over 7% at $6.98.
Enveric Biosciences, Inc. (ENVB) is up over 6% at $1.32.
Semler Scientific, Inc. (SMLR) is up over 6% at $47.76.
Sharps Technology, Inc. (STSS) is up over 4% at $4.00.
Forte Biosciences, Inc. (FBRX) is up over 4% at $7.46.
Vistagen Therapeutics, Inc. (VTGN) is up over 4% at $2.55.
aTyr Pharma, Inc. (ATYR) is up over 4% at $3.93.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update -June 15 - June 19, 2026

June 19, 2026 16:46 ET
Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.